JJJulius Juodakis

Julius Juodakis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Julius Juodakis has a total of 273 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Maternal age-related differences in the timing of pregnancy loss in a nationwide ART cohort

    by Felix Evers, Karin Ytterberg, Alba Rocio Ramirez Jimenez, Yan Zhao, Patricia Nyeboe, Maria C Magnus, Julius Juodakis, Bo Jacobsson, Pol Solé-Navais

    Study question: Are maternal age and a history of previous pregnancy losses associated with the timing of pregnancy loss for women undergoing ART treatment? Summary answer: Among women who underwent ART treatment, younger women had a higher risk of very early biochemical pregnancy losses. Women with previous pregnancy losses overall experienced pregnancy losses at an earlier gestational age. What is known already: Maternal age and history of pregnancy loss are two of the strongest, independent determinants of pregnancy loss risk. Study design, size, duration: This retrospective cohort study comprises all embryo transfers in Sweden between 2007 and 2022 (n = 202,008). The Swedish Quality Register for Assisted Reproduction (Q-IVF) provides information on confirmed pregnancies from two weeks after embryo transfer. Additional information was retrieved from the Swedish Medical Birth Register and the National Patient Register. Participants/materials, setting, methods: We studied 202,008 embryo transfers resulting in 80,673 biochemically verified pregnancies and 21,240 pregnancy losses. We assessed the associations between two exposures (maternal age and history of pregnancy loss) and four outcomes (implantation failure, pregnancy loss, the proportion of pregnancy losses occurring within the biochemical pregnancy window, and the gestational duration when the pregnancy loss was diagnosed). Fixed and mixed linear and logistic regression models were used, the latter to account for unmeasured confounding shared across pregnancies from the same mothers. Through analyses of subgroups including oocyte recipients (n = 3,558) and women undergoing treatment due to male infertility (n = 41,721), we attempted to tease out the effects of potential unmeasured confounders, such as maternal oocyte aneuploidies. Main results and the role of chance: Mean maternal age was 34 years, 23 % had a history of pregnancy loss, implantation failure occurred after 60 % of embryo transfers and pregnancy loss occurred in 26 % after successful implantation. Higher maternal age was associated with increased risk of implantation failure (OR = 1.02 per year; 95% CI = 1.02, 1.02), and pregnancy loss after successful implantation (OR = 1.05 per year; 95% CI = 1.05, 1.06). We observed no relationship between maternal age and the risk of implantation failure or pregnancy loss among women undergoing ART with donated oocytes. Among those who experienced pregnancy loss, the proportion of pregnancy losses within the biochemical window decreased with increasing maternal age (OR = 0.94 per year; 95% CI = 0.93, 0.94), a result consistent across all subgroups and regardless of oocyte origin. The number of previous pregnancy losses was associated with a lower risk of implantation failure (OR = 0.82; 95% CI = 0.81, 0.84), but not with pregnancy loss in the index pregnancy after accounting for within-women correlations using mixed-effects models (OR = 1.02; 95% CI= 0.99, 1.04). Limitations, reasons for caution: Since all women studied underwent ART treatment, the findings may not apply to naturally conceived pregnancies. The gestational duration of pregnancy losses reflects the time at diagnosis, and thus is an upper bound for the pregnancy loss. Wider implications of the findings: This study confirms (oocyte) maternal age and history of pregnancy loss as influential in risk of implantation failure and pregnancy loss, and suggests that maternal age may delay the timing of the pregnancy loss, particularly among pregnancy losses occurring within the biochemical pregnancy window. Study funding/competing interest(s): Funding for this research project was granted by the Swedish Research Council; the Swedish Society for Medical Research; the Agreement concerning research and education of doctors; FORTE; Swedish Research Council for Health, Working Life and Welfare; the Hjalmar Svensson Foundation; the Research Council of Norway. The authors declare no conflicts of interest. Trial registration number: N/A

  • Open Access

    Auxin‐related regulation of barley floral organ fate: genetic and phenotypic insights from tweaky spike mutants

    by Vėjūnė Pukenytė, Bernadeta Kaminskaitė‐Mačė, Miglė Remeikytė, Jurga Jankauskienė, Julius Juodakis, Sigita Jurkonienė, Algė Leistrumaitė, Ljudmilla Timofejeva, Virginija Vaitkūnienė, Justas Stonkus, et al.

    Summary: Mutant‐based research is a cornerstone for elucidating gene function in barley ( Hordeum vulgare ) and other cereals. In this study, we exploited a unique collection of barley tweaky spike ( tw ) mutants to identify the locus controlling floret and spike development. We combined genetic mapping with structural variant and gene‐expression analyses across a tw allelic series, supported by functional validation, and quantified endogenous auxin levels alongside auxin‐application assays to test phytohormone involvement. Analysis of independent tw allelic mutants revealed that the phenotype results from loss of function of HvAP2L5 , most often due to complete open reading frame (ORF) deletions, and, in one allele, due to transcriptional silencing. tw mutants showed a reproducible endogenous indole‐3‐acetic acid deficit, and exogenous auxin could partially phenocopy and/or rescue core tw‐ associated traits, indicating compromised auxin homeostasis. We conclude that HvAP2L5 is essential for normal spike/floret development and that its loss disrupts auxin balance. Auxin imbalance is a compelling working model that can account for most of the pleiotropic features of tw mutants.

  • Open Access

    Lithuania’s National Digital Health System Architecture, Evolution, and Lessons From a Centralized Approach Using Longitudinal Document Analysis: Descriptive National Case Study

    by Austėja Dapkutė, Olegas Niakšu, Julius Juodakis, Danguolė Jankauskienė, Justas Trinkūnas, Arvydas Laurinavičius, Tomas Jovaiša, Donata Ringaitienė, Martyna Atraškevičienė, Rytis Masiliūnas

    Background: National digital health systems are increasingly recognized as a key tool for strengthening health care systems and improving patient outcomes. Global guidance from the World Health Organization and European Union initiatives emphasizes interoperability, robust data governance, and secure exchange of health information as prerequisites for system-wide benefits. However, translating these principles into operational national digital health infrastructures remains challenging, and empirical evidence on long-term, centralized implementation models is limited. Lithuania is among a small number of European countries that have implemented a fully centralized national digital health platform (DHP), providing a valuable case for examining the development, structure, and performance of such systems. Objective: This study aimed to describe and analyze Lithuania’s national digital health system across its historical development, governance, technical architecture, interoperability and adoption, and to identify challenges and lessons learned. Methods: We conducted a descriptive national case study of Lithuania’s digital health system using longitudinal document analysis. Publicly available policy documents, legislation, strategy reports, audits, and official statistics published between 2000 and 2025 were systematically reviewed following the readying, extracting, analyzing, and distilling (READ) framework. Thematic analysis was applied to examine governance, system architecture, interoperability, adoption, and implementation challenges. Peer-reviewed literature was used for contextualization. Results: Lithuania’s digital health system evolved from fragmented initiatives in the early 2000s into a fully centralized national DHP that has been operational nationwide since 2015. Since 2018, health care providers have been required to record core clinical data electronically, and all reimbursed medicines are prescribed exclusively through the national electronic prescription system. The DHP integrates electronic health records, electronic prescription system, appointment booking, and other national subsystems with standardized interfaces. System use expanded rapidly: the annual number of electronic documents stored in the DHP increased from approximately 7 million in 2017 to over 100 million in 2024, reflecting widespread uptake of outpatient documentation, referrals, and prescriptions. Patient-facing services, including online access to records and a nationwide appointment booking system, also expanded, although patient-initiated use remains uneven across regions. The platform supports secure primary use for care delivery and secondary use of health data through a centralized access pathway. While core services have reached national scale, some subsystems, such as imaging exchange and telemedicine, remain less mature. Ongoing modernization focuses on improving data interoperability, enabling advanced analytics and future AI-based services, strengthening cross-border eHealth services, and extending coverage to sensitive and previously excluded domains such as mental health, maternal, and newborn care through dedicated subsystems. Conclusions: Lithuania’s centralized digital health system illustrates both the potential and the limitations of national-scale integration driven by legal mandates and standardized interoperability. Its experience provides transferable insights for health systems seeking to consolidate fragmented infrastructures while maintaining data security, regulatory compliance, and long-term system adaptability.

  • Open Access

    Machine Learning-based Prediction of Preterm Birth Using Genetic Data

    by Hedvig Sundelin, Bo Jacobsson, Karin Ytterberg, Pol Sole-Navais, Julius Juodakis

    The leading cause of mortality and morbidity in children under the age of 5 is preterm birth. The timing of birth is influenced by both genetic and environmental factors, but the underlying mechanisms remain poorly understood, making its prediction difficult. In this study, we investigated the potential of using machine learning models to predict preterm birth based on genetic data from the Norwegian Mother, Father and Child Cohort Study (MoBa). We trained and evaluated several classification algorithms on individual-level genetic data from over 15,000 mothers and children. Our results indicate that the predictive capacity of maternal gestational duration-associated loci for preterm birth is limited, with the highest AUC values around 0.57. Additionally, incorporating more SNPs within the associated loci did not improve prediction performance. As expected, the contribution of the maternal genome to preterm birth prediction was found to be larger than that of the fetal genome. Overall, our findings suggest that while genetic testing provides some information about an individual’s risk for preterm birth, further research incorporating additional factors is necessary to enhance predictability.

  • Open Access

    Lithuania’s National Digital Health System Architecture, Evolution, and Lessons From a Centralized Approach Using Longitudinal Document Analysis: Descriptive National Case Study (Preprint)

    by Austėja Dapkutė, Olegas Niakšu, Julius Juodakis, Danguolė Jankauskienė, Justas Trinkūnas, Arvydas Laurinavičius, Tomas Jovaiša, Donata Ringaitienė, Martyna Atraškevičienė, Rytis Masiliūnas

    BACKGROUND National digital health systems are increasingly recognized as a key tool for strengthening health care systems and improving patient outcomes. Global guidance from the World Health Organization and European Union initiatives emphasizes interoperability, robust data governance, and secure exchange of health information as prerequisites for system-wide benefits. However, translating these principles into operational national digital health infrastructures remains challenging, and empirical evidence on long-term, centralized implementation models is limited. Lithuania is among a small number of European countries that have implemented a fully centralized national digital health platform (DHP), providing a valuable case for examining the development, structure, and performance of such systems. OBJECTIVE This study aimed to describe and analyze Lithuania’s national digital health system across its historical development, governance, technical architecture, interoperability and adoption, and to identify challenges and lessons learned. METHODS We conducted a descriptive national case study of Lithuania’s digital health system using longitudinal document analysis. Publicly available policy documents, legislation, strategy reports, audits, and official statistics published between 2000 and 2025 were systematically reviewed following the readying, extracting, analyzing, and distilling (READ) framework. Thematic analysis was applied to examine governance, system architecture, interoperability, adoption, and implementation challenges. Peer-reviewed literature was used for contextualization. RESULTS Lithuania’s digital health system evolved from fragmented initiatives in the early 2000s into a fully centralized national DHP that has been operational nationwide since 2015. Since 2018, health care providers have been required to record core clinical data electronically, and all reimbursed medicines are prescribed exclusively through the national electronic prescription system. The DHP integrates electronic health records, electronic prescription system, appointment booking, and other national subsystems with standardized interfaces. System use expanded rapidly: the annual number of electronic documents stored in the DHP increased from approximately 7 million in 2017 to over 100 million in 2024, reflecting widespread uptake of outpatient documentation, referrals, and prescriptions. Patient-facing services, including online access to records and a nationwide appointment booking system, also expanded, although patient-initiated use remains uneven across regions. The platform supports secure primary use for care delivery and secondary use of health data through a centralized access pathway. While core services have reached national scale, some subsystems, such as imaging exchange and telemedicine, remain less mature. Ongoing modernization focuses on improving data interoperability, enabling advanced analytics and future AI-based services, strengthening cross-border eHealth services, and extending coverage to sensitive and previously excluded domains such as mental health, maternal, and newborn care through dedicated subsystems. CONCLUSIONS Lithuania’s centralized digital health system illustrates both the potential and the limitations of national-scale integration driven by legal mandates and standardized interoperability. Its experience provides transferable insights for health systems seeking to consolidate fragmented infrastructures while maintaining data security, regulatory compliance, and long-term system adaptability.

  • Open Access

    Parity modifies the effect of genetic variants associated with gestational duration and birth weight

    by Karin Ytterberg, Hedvig Sundelin, Julius Juodakis, Marc Vaudel, Elizabeth C. Corfield, Ole A. Andreassen, Per Magnus, Alexandra Havdahl, Staffan Nilsson, Pål R. Njolstad, et al.

    Gestational duration and birth weight are linked to both short- and long-term adverse health outcomes in mothers and their offspring. Previous genome-wide association studies on these pregnancy outcomes have been successful but have overlooked the number of a mother’s previous pregnancies. In this study, we explored if parity (the number of children a mother has previously delivered) modifies the maternal or foetal genetic effect of gestational duration and birth weight (gene × parity interactions) using data from the Norwegian Mother, Father, and Child Cohort Study in up to 58,528 mothers and their offspring. Potential genetic effect differences were investigated by: (1) performing parity-stratified genome-wide association studies, (2) testing SNP × parity interactions, (3) testing the interaction between a polygenic prediction of the traits and parity, and (4) assessing the genetic correlation within each outcome across parity. For both phenotypes, we identified shared and distinct loci for each outcome in terms both of genetic region and number in the parity-stratified genome-wide association studies, and the genetic correlation by parity deviated from one for all outcomes. The strongest evidence of genetic modification effect by parity was found for gestational duration in the maternal genome where genetic effects were stronger in the first pregnancy compared to later pregnancies. For instance, the polygenic prediction of the maternal genome on gestational duration had a significant interaction with parity (p-value interaction = 5 × 10 -5 ). The results for birth weight were more uncertain, suggesting that the identified gene × parity interactions is largely limited to gestational duration. In conclusion, our study reveals that parity modifies the genetic effects on gestational duration and highlights the relevance of considering parity in genetic studies on pregnancy outcomes.


  • Open Access

    Data Resource Profile: The Lithuanian health data reuse pathway

    by Julius Juodakis, Simona Zubavičiūtė, Austėja Dapkutė, Saulė Greičienė, Rytis Masiliūnas, Indrė Narkevičienė, Justas Trinkūnas, Julija Žemaitytė, Gita Literskė


  • Open Access

    Haplotype-based analysis distinguishes maternal-fetal genetic contribution to pregnancy-related outcomes

    by Amit K. Srivastava, Julius Juodakis, Pol Sole-Navais, Jing Chen, Jonas Bacelis, Kari Teramo, Mikko Hallman, Pal R. Njølstad, David M. Evans, Bo Jacobsson, et al.

    Genotype-based approaches for the estimation of SNP-based narrow-sense heritability ( h^2 ) have limited utility in pregnancy-related outcomes due to confounding by the shared alleles between mother and child. Here, we propose a haplotype-based approach to estimate the genetic variance attributable to three haplotypes - maternal transmitted ( h^m12 ), maternal non-transmitted ( h^m22 ) and paternal transmitted ( h^p12 ) in mother-child pairs. We show through extensive simulations that our haplotype-based approach outperforms the conventional and contemporary approaches for resolving the contribution of maternal and fetal effects, particularly when m1 and p1 have different effects in the offspring. We apply this approach to estimate the explicit and relative maternal-fetal genetic contribution to the phenotypic variance of gestational duration and gestational duration-adjusted fetal size measurements at birth in 10,375 mother-child pairs. The results reveal that variance of gestational duration is mainly attributable to m1 and m2 ( h^m12=17.3%,S.E.=5.2%;h^m22=12.2%,S.E.=5.2%;h^p12=0.0%,S.E.=5.0% ). In contrast, variance of fetal size measurements at birth are mainly attributable to m1 and p1 ( h^m12=18.6−36.4%,h^m22=0.0−5.2% and h^p12=4.4−13.6% ). Our results suggest that gestational duration and fetal size measurements are primarily genetically determined by the maternal and fetal genomes, respectively. In addition, a greater contribution of m1 as compared to m2 and p1 ( h^m12−h^m22−h^p12>0 ) to birth length and head circumference suggests a substantial influence of correlated maternal-fetal genetic effects on these traits. Our newly developed approach provides a direct and robust alternative for resolving explicit maternal and fetal genetic contributions to the phenotypic variance of pregnancy-related outcomes.


  • Open Access

    The influence of fetal sex on maternal blood pressure in pregnancy

    by Caitlin S. Decina, Robin N. Beaumont, Julius Juodakis, Nicole M. Warrington, Kashyap A. Patel, Pål R. Njølstad, Stefan Johansson, Andrew T. Hattersley, Bo Jacobsson, William L. Lowe, et al.

    Background Pregnancy with a male fetus carries a higher risk of term pre-eclampsia than pregnancy with a female fetus. Based on evidence that maternal blood pressure (BP) may be raised in pregnancies with Beckwith-Wiedemann syndrome (fetal overgrowth), a possible contributing factor to the association between male sex and term pre-eclampsia is that males grow faster, reaching ∼130 g higher birth weight, on average, than females. The association between fetal sex and maternal BP in healthy pregnancies is not known. We hypothesized that male sex would be associated with higher maternal BP in healthy pregnancies, and that this association would be explained by birth weight differences between males and females. Methods and findings We tested the association between fetal sex and maternal systolic (SBP) and diastolic blood pressure (DBP), measured at ∼28 weeks of gestation, in a meta-analysis of five different cohorts of mother-child pairs (n up to 109,842). Maternal BP was analyzed as both a continuous and dichotomized (high BP: yes or no) outcome. Linear regression models were constructed with and without adjustment for birth weight to assess whether any difference in maternal BP was explained by the difference in birth weight between male and female babies. Lastly, we constructed a fetal genetic score for birth weight using 186 own-birth-weight-associated single-nucleotide polymorphisms (SNPs) to test whether birth-weight-raising-alleles in the fetus were associated with maternal BP in pregnancy (n up to 32,232). Both maternal SBP and DBP were higher in pregnancy when carrying a male fetus compared to a female fetus (mean difference 0.35 mmHg [95%CI: 0.15-0.55] and 0.35 mmHg [95%CI: 0.21-0.49], for SBP and DBP, respectively). An independent effect of fetal sex remained when including birth weight but attenuated slightly (0.22 mmHg [95%CI: 0.02-0.42] and 0.31 mmHg [95%CI: 0.17-0.45], for SBP and DBP respectively). A positive effect estimate was found for odds of experiencing high maternal BP given pregnancy with a male fetus, but confidence intervals were wide (OR 1.05 [95%CI: 0.98-1.12]). No evidence for an association was found between a fetal birth weight genetic score and SBP or DBP when conditioned on maternal genotype. Conclusions We found strong evidence to support a small effect of male fetal sex on higher maternal BP in pregnancy and that larger fetal size at birth does not contribute to a substantial part of this association. Our findings do not indicate a difference in maternal BP that would warrant changes to routine monitoring in clinical practice but do suggest that male sex may be a contributing risk factor for BP-related complications.


  • Author Correction: Characterization of the genetic architecture of infant and early childhood body mass index

    by Øyvind Helgeland, Marc Vaudel, Pol Sole-Navais, Christopher Flatley, Julius Juodakis, Jonas Bacelis, Ingvild L. Koløen, Gun Peggy Knudsen, Bente B. Johansson, Per Magnus, et al.